Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children

Overview of attention for article published in New England Journal of Medicine, February 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 131 X posts from 117 X users, with an upper bound of 1,323,303 followers.

@BigBadDenis @qldhealth @ShannonFentiman 71% effective based on comparison of 306 case patients to 1224 controls https://t.co/eO9azIwBAb.

@Mahflamenace @Arwed1211 Pfizer et Moderna avaient plus de 95% d'efficacité contre la souche sauvage contre laquelle ils ont été conçus. Méningocoque ? 76% ⬇️ https://t.co/Q9w4fNczUb. Pneumocoque ? Entre 45% et 75% ⬇️ https://t.co/IfhIa6d4G1

Nou article a #Docusalut: Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children https://t.co/Msb4zfOLza @SalutGOIB #PUblicaSAlutIB https://t.co/xlco9zo8mo

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 127 additional X posts.